These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 16204367)
1. Hyperparathyroidism in persons exposed to iodine-131 from the Hanford Nuclear Site. Hamilton TE; Davis S; Onstad L; Kopecky KJ J Clin Endocrinol Metab; 2005 Dec; 90(12):6545-8. PubMed ID: 16204367 [TBL] [Abstract][Full Text] [Related]
2. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. Davis S; Kopecky KJ; Hamilton TE; Onstad L; JAMA; 2004 Dec; 292(21):2600-13. PubMed ID: 15572718 [TBL] [Abstract][Full Text] [Related]
3. Thyroid ultrasound abnormalities in persons exposed during childhood to 131I from the Hanford nuclear site. Kopecky KJ; Onstad L; Hamilton TE; Davis S Thyroid; 2005 Jun; 15(6):604-13. PubMed ID: 16029129 [TBL] [Abstract][Full Text] [Related]
4. Estimation of thyroid radiation doses for the hanford thyroid disease study: results and implications for statistical power of the epidemiological analyses. Kopecky KJ; Davis S; Hamilton TE; Saporito MS; Onstad LE Health Phys; 2004 Jul; 87(1):15-32. PubMed ID: 15194919 [TBL] [Abstract][Full Text] [Related]
5. Cancer mortality among populations residing in counties near the Hanford site, 1950-2000. Boice JD; Mumma MT; Blot WJ Health Phys; 2006 May; 90(5):431-45. PubMed ID: 16607175 [TBL] [Abstract][Full Text] [Related]
6. Population exposures to I-131 releases from Hanford Nuclear Reservation and preterm birth, infant mortality, and fetal deaths. Tatham LM; Bove FJ; Kaye WE; Spengler RF Int J Hyg Environ Health; 2002 Mar; 205(1-2):41-8. PubMed ID: 12018015 [TBL] [Abstract][Full Text] [Related]
7. Juvenile hypothyroidism among two populations exposed to radioiodine. Goldsmith JR; Grossman CM; Morton WE; Nussbaum RH; Kordysh EA; Quastel MR; Sobel RB; Nussbaum FD Environ Health Perspect; 1999 Apr; 107(4):303-8. PubMed ID: 10090710 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of an epidemiologic study of thyroid neoplasia in persons exposed to radionuclides from the Hanford nuclear facility between 1944 and 1956. Cate S; Ruttenber AJ; Conklin AW Health Phys; 1990 Aug; 59(2):169-78. PubMed ID: 2370141 [TBL] [Abstract][Full Text] [Related]
9. Risk of thyroid cancer after exposure to 131I in childhood. Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042 [TBL] [Abstract][Full Text] [Related]
11. An evaluation of the risk of developing hyperparathyroidism after 131I treatment for thyrotoxicosis. Fjälling M; Dackenberg A; Hedman I; Tisell LE Acta Chir Scand; 1983; 149(7):681-6. PubMed ID: 6650083 [TBL] [Abstract][Full Text] [Related]
12. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data. Lyon JL; Alder SC; Stone MB; Scholl A; Reading JC; Holubkov R; Sheng X; White GL; Hegmann KT; Anspaugh L; Hoffman FO; Simon SL; Thomas B; Carroll R; Meikle AW Epidemiology; 2006 Nov; 17(6):604-14. PubMed ID: 17028502 [TBL] [Abstract][Full Text] [Related]
13. A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. Tronko MD; Howe GR; Bogdanova TI; Bouville AC; Epstein OV; Brill AB; Likhtarev IA; Fink DJ; Markov VV; Greenebaum E; Olijnyk VA; Masnyk IJ; Shpak VM; McConnell RJ; Tereshchenko VP; Robbins J; Zvinchuk OV; Zablotska LB; Hatch M; Luckyanov NK; Ron E; Thomas TL; Voillequé PG; Beebe GW J Natl Cancer Inst; 2006 Jul; 98(13):897-903. PubMed ID: 16818853 [TBL] [Abstract][Full Text] [Related]
14. [An evaluation of the incidence of hyperparathyroidism after 131I treatment for Basedow disease (Part II)]. Ito K; Tsuchiya T; Sugino K; Murata M Kaku Igaku; 1996 Jul; 33(7):737-42. PubMed ID: 8803442 [TBL] [Abstract][Full Text] [Related]
16. [Study of the possibility of hyperparathyroidism development in rats exposed to internal irradiation by iodine radioisotope]. Budagov RS; Chureeva LN; Chibisova OF; Barbarykina GS; Petrov VN; Podgorodnichenko VK; Belorukova NV Radiats Biol Radioecol; 2002; 42(1):80-5. PubMed ID: 11898637 [TBL] [Abstract][Full Text] [Related]
17. The Hanford Thyroid Disease Study: an alternative view of the findings. Hoffman FO; Ruttenber AJ; Apostoaei AI; Carroll RJ; Greenland S Health Phys; 2007 Feb; 92(2):99-111. PubMed ID: 17220711 [TBL] [Abstract][Full Text] [Related]
18. [Hyperparathyroidism after radioactive iodine therapy for Graves' disease: a case report]. Kawamura J; Tobisu K; Sanada S; Okada Y; Yoshida O; Minami S; Hino M; Shigeno T; Konishi J; Morita R Hinyokika Kiyo; 1983 Nov; 29(11):1513-9. PubMed ID: 6689566 [TBL] [Abstract][Full Text] [Related]
19. Hyperparathyroidism after radioactive iodine therapy. Colaço SM; Si M; Reiff E; Clark OH Am J Surg; 2007 Sep; 194(3):323-7. PubMed ID: 17693276 [TBL] [Abstract][Full Text] [Related]
20. Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine. Rasmuson T; Tavelin B Acta Oncol; 2006; 45(8):1059-61. PubMed ID: 17118839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]